CEE VC SUMMIT 2026

Switzerland
March 31, 2026

Swiss startup Delta Labs raises €4.4M to grow AI customer simulation tool

The seed round was supported by Cusp Capital and Auxxo Female Catalyst Fund.

March 18, 2026

Swiss firm Rivia raises €13M to enhance clinical trial data operations with AI

The Series A round was led by Earlybird, with support from Defiant and existing backers.

March 10, 2026

Swiss biotech firm Seprify secures €13.4M to scale cellulose materials for industry

The Series A was backed by Inter IKEA Group, Una Terra Early Growth Fund, and Zürcher Kantonalbank (ZKB).

January 28, 2026

b2venture closes €150M Fund V to back Europe’s next-Gen tech leaders

Fund V was supported by a mix of long-standing and new limited partners, including family offices, institutional investors like Flexstone and Stiftung Abendrot.

January 23, 2026

Oviva raises €200M series D to expand AI-enabled chronic care across Europe

The round saw support from Kinnevik, Planet First Partners, A.P. Moller Holding, Lunate, EGS Beteiligungen, Norrsken VC, and existing backer Sofina.

January 22, 2026

Switzerland VC firm Vi Partners closes €161M early-stage venture fund

The fresh fund was backed by Vi Partners’ current limited partners.

January 12, 2026

Swiss biotech startup FluoSphera raises €1.23M led by Soulmates Ventures

The fresh capital was backed by Soulmates Ventures, a Swiss business angel, and IndieBio New York.

December 19, 2025

Swiss firm Neural Concept secures $100M Series C to scale AI-native engineering

The round was led by Growth Equity at Goldman Sachs Alternatives, with participation from Forestay Capital, Alven, HTGF, D.E. Shaw Ventures, and Aster Capital.